3.8(Q2)
CiteScore
27
h-index

Exploring the Anti-Inflammatory and Apoptotic Potential of Nigella Sativa Compounds via Bioinformatics and Molecular Docking

Document Type : Original Research Article

Authors

1 Doctoral Program of Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, East Java, Indonesia

2 Division of Veterinary Reproduction, Faculty of Veterinary Medicine, Universitas Brawijaya, Malang, Indonesia

3 Division of Veterinary Anatomy, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia

4 Division of Veterinary Reproduction, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia

5 Department of Veterinary Medicine Science, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia

6 Division of Veterinary Pharmacology, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia

7 Division of Veterinary Science (Animal Nutrition), Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia

8 Division of Veterinary Pathology, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia

Abstract
Nigella sativa is widely recognized for its anti-inflammatory, antioxidant, and immunomodulatory activities; yet, a systematic in silico assessment of its major phytocompounds against inflammation- and apoptosis-related targets remains limited. This study employed an integrated bioinformatics and molecular docking approach to evaluate the drug-likeness, toxicity, predicted bioactivity, and protein ligand interactions of four key Nigella sativa constituents: thymoquinone, thymohydroquinone, nigellidine, and nigellicine. Druglikeness and pharmacokinetic properties were analyzed using SwissADME, toxicity was predicted through ProTox 3.0, and bioactivity profiles were estimated using PASS Online. Molecular docking simulations were conducted using AutoDock Vina targeting TNF‑α (PDB: 2AZ5) and caspase‑3 (PDB: 3KJF), followed by interaction visualization in Discovery Studio 2024. All compounds satisfied Lipinski’s Rule of Five, suggesting good oral drug-likeness, with nigellicine showing the highest predicted bioavailability score (0.85). Thymoquinone and thymohydroquinone demonstrated the safest toxicity profiles, whereas nigellidine and nigellicine indicated possible organ-specific risks. Docking results showed that nigellidine exhibited the strongest binding affinity to TNF‑α (–8.2 kcal/mol) and caspase‑3 (–6.7 kcal/mol), forming stable interactions with key active-site residues. Overall, these findings highlight nigellidine and nigellicine as promising dual-target inhibitors with potential therapeutic relevance for inflammation and apoptosis-associated conditions. This work supports the development of natural bioactive compounds and aligns with Sustainable Development Goal 3 (Good Health and Well-being).

Graphical Abstract

Exploring the Anti-Inflammatory and Apoptotic Potential of Nigella Sativa Compounds via Bioinformatics and Molecular Docking

Keywords

Subjects


©2026 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

[1] Sirmans, S.M., Pate, K.A. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology, 2013, 1-13.
[2] Woo, C.C., Kumar, A.P., Sethi, G., Tan, K.H.B. Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochemical Pharmacology, 2012, 83(4), 443-451.
[3] Kunitomi, C., Harada, M., Sanada, Y., Kusamoto, A., Takai, Y., Furui, T., Kitagawa, Y., Yamada, M., Watanabe, C., Tsugawa, K. The possible effects of the japan society of clinical oncology clinical practice guidelines 2017 on the practice of fertility preservation in female cancer patients in Japan. Reproductive Medicine and Biology, 2022, 21(1), e12453.
[4] Hannan, M.A., Rahman, M.A., Sohag, A.A.M., Uddin, M.J., Dash, R., Sikder, M.H., Rahman, M.S., Timalsina, B., Munni, Y.A., Sarker, P.P., Alam, M., Mohibbullah, M., Haque, M.N., Jahan, I., Hossain, M.T., Afrin, T., Rahman, M.M., Tahjib-Ul-Arif, M., Mitra, S., Kim, B. Black cumin (Nigella sativa L.): A comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients, 2021, 13(6), 1784.
[5] Ibrahim, I.M., Oluchukwu, N.V., Salisu, A., Nkemakonam, O.M. Nutritional and phytochemical analysis of spinach leaf aqueous extract: A comprehensive study on proximate composition, minerals, vitamins, and antioxidant activity. Eurasian Journal of Science and Technology, 2025, 5(3), 302-311.
[7] Bijeh, K.M.H., Omidi, H. Study of the botanical, phytochemical, and pharmacological properties of artemisia annua L. International Journal of Advanced Biological and Biomedical Research, 13(2), 78-89. 2025.
[8] Daina, A., Michielin, O., Zoete, V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 2019, 47(W1), W357-W364.
[10] Banerjee, P., Kemmler, E., Dunkel, M., Preissner, R. ProTox 3.0: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 2024, 52(W1), W513-W520.
[11] Filimonov, D., Lagunin, A., Gloriozova, T., Rudik, A., Druzhilovskii, D., Pogodin, P., Poroikov, V. Prediction of the biological activity spectra of organic compounds using the pass online web resource. Chemistry of Heterocyclic Compounds, 2014, 50(3), 444-457.
[12] Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T.H., Von Mering, C., Jensen, L.J., Bork, P. STITCH 4: Integration of protein–chemical interactions with user data. Nucleic Acids Research, 2014, 42(D1), D401-D407.
[13] Ukwubile, C.A., Lawan, M.Z., Lawal, F.A. Phytochemical analysis and evaluation of anticancer and antioxidant activities of vitellaria paradoxa gaertn (sapotaceae) methanol stembark extract. International Journal of Advanced Biological and Biomedical Research, 2025, 13(5), 487-499.
[14] Szklarczyk, D., Gable, A.L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N.T., Morris, J.H., Bork, P. String v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 2019, 47(D1), D607-D613.
[15] Puri, J.B., Shaikh, A.M., Dhuldhaj, U.P. Phytochemical and biochemical analysis of ajwain seed’s content. Eurasian Journal of Science and Technology, 2024, 4(1).
[16] Pillai, M.K., Simelane, T. Antioxidant activity and phytochemical analysis of extracts from acacia gerrardii: A medicinal plant from the kingdom of eswatini. International Journal of Advanced Biological and Biomedical Research,  2025, 13(1), 48-60.
[17] Kumar, A., Singh, A.K., Singh, H., Vijayan, V., Kumar, D., Naik, J., Thareja, S., Yadav, J.P., Pathak, P., Grishina, M., et al. Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective. Pharmaceuticals, 2023, 16(2), 299.
[18] Lipinski, C.A. Lead-and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 2004, 1(4), 337-341.
[19] Pop, R.M., Sabin, O., Suciu, Ș., Vesa, S.C., Socaci, S.A., Chedea, V.S., Bocsan, I.C., Buzoianu, A.D. Nigella sativa’s anti-inflammatory and antioxidative effects in experimental inflammation. Antioxidants, 2020, 9(10), 921.
[20] Mir, S.A., Nayak, B., Khan, A., Khan, M.I., Eldakhakhny, B.M., Arif, D.O. An exploration of binding of hesperidin, rutin, and thymoquinone to acetylcholinesterase enzyme using multi‑level computational approaches. Journal of Biomolecular Structure and Dynamics, 2024, 42(21), 11901–11915.
Volume 10, Issue 3
May and June 2026
Pages 539-547

  • Receive Date 01 November 2025
  • Revise Date 24 November 2025
  • Accept Date 29 December 2025